Case Report
Pure Androgen-Secreting Adrenal Adenoma Associated with Resistant Hypertension
Table 1
Laboratory measures.
| | Value | Basal | After surgery | Range |
| | FSH (UI/L) | 4.41 | — | (2–12) | | LH (UI/L) | 4.24 | — | (1–18) | | Estradiol (pg/mL) | 197.90 | — | (15–350) | | Prolactin (ng/mL) | 21.18 | — | (4–30) | | 17-Hydroxyprogesterone (ng/dL) | 25 | — | (20–300) | | Androstenedione (ng/mL) | 10 | 0.3 | (0.4–2.7) | | Testosterone (ng/mL) | 4.33 | 0.24 | (0.06–0.82) | | DHEA-S (/dL) | >1000 | 31.3 | (35–430) | | 11-DOC (ng/dL) | 5.3 | — | (1.5–37) | | ACTH (pg/mL) | 17.14 | — | (10–60) | | Progesterone (ng/mL) | 1 | — | (2–20) | | UFC (ug/day) | 18.4 | — | (36–137) | | PM (pg/mL) | 21 | — | (≤57) | | TUM ug/24 hrs | 194 | — | (25–300) | | PAC (ng/dL) | 25 | — | (2–18) | | PRA (ng/mL/hr) | 10.5 | — | (0.25–5.82) | | PAC/PAR | 2.38 | — | <30 |
|
|
FSH: follicle-stimulating hormone; LH: luteinizing hormone; DHEA-S: dehydroepiandrosterone sulfate; 11-DOC: 11-deoxycorticosterone; ACTH: adrenocorticotropic hormone; UFC: urinary free cortisol; PM: plasma metanephrines; TUM: total urinary metanephrines; PAC: plasmatic aldosterone concentration; PRA: plasmatic renin activity.
|
